Delving into the Latest Updates on Heart Metabolics Ltd. with Synapse

概览

关联

3

项与 Heart Metabolics Ltd. 相关的临床试验

NCT02862600 / Terminated临床2期

A Phase 2, Multi-Center, Open-Label, Ascending Dose Study on the Efficacy, Safety and Tolerability of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure With Preserved Left Ventricular Function

The purpose of this study is to evaluate the effect of perhexiline on exercise performance (efficacy) and safety in patients with hypertrophic cardiomyopathy and moderate-to-severe heart failure following dosing for 16 weeks.

开始日期2016-08-01

申办/合作机构

Heart Metabolics Ltd.

ACTRN12614001281684 / Active, not recruiting临床1期

A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel Design Study to Evaluate the Effects of Perhexiline on ECG Parameters in Healthy Subjects

开始日期2014-12-02

申办/合作机构

Heart Metabolics Ltd.

[+1]

NCT02431221 / Withdrawn临床3期

A Study on the Efficacy, Safety, and Tolerability of Perhexiline Maleate in Subjects With Hypertrophic Cardiomyopathy and Moderate-To-Severe Heart Failure

A Study on the Efficacy, Safety, and Tolerability of Perhexiline maleate in Subjects with Hypertrophic Cardiomyopathy and Moderate-To-Severe Heart Failure

开始日期-

申办/合作机构

Heart Metabolics Ltd.

100 项与 Heart Metabolics Ltd. 相关的临床结果

登录后查看更多信息

0 项与 Heart Metabolics Ltd. 相关的专利（医药）

登录后查看更多信息

100 项与 Heart Metabolics Ltd. 相关的药物交易

登录后查看更多信息

100 项与 Heart Metabolics Ltd. 相关的转化医学

登录后查看更多信息